Drug Profile
Dapsone topical - Almirall S.A.
Alternative Names: 5% Topical dapsone gel - Novelion Therapeutics; 7.5% Topical dapsone gel - Allergan; Aczone; AtrisoneLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator QLT
- Developer Almirall S.A.; Novelion Therapeutics
- Class Anti-inflammatories; Antiacnes; Antibacterials; Antileprotics; Antimalarials; Antivirals; Small molecules; Sulfones
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris